Tain You-Lin, Chang Sam K C, Liao Jin-Xian, Chen Yu-Wei, Huang Hung-Tse, Li Yu-Lun, Hou Chih-Yao
Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.
Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.
Antioxidants (Basel). 2021 Mar 10;10(3):420. doi: 10.3390/antiox10030420.
To expand the applications and enhance the stability and bioactivity of resveratrol (RE), and to simultaneously include the potential health benefits of short chain fatty acids (SCFA) esters of RE were prepared by Steglich reactions with acetic, propionic, and butyric acids, respectively. RE and the esterified RE-SCFA products (including RAE, RPE, and RBE) were analyzed using nuclear magnetic resonance (NMR), Fourier-transform infrared (FTIR) spectroscopy, thermogravimetric analysis (TGA), differential thermal analysis (DTA), and liquid chromatography-mass spectrometry (LC-MS). The FTIR and C NMR spectra of the esterified products included ester-characteristic peaks at 1751 cm and 171 ppm, respectively. Moreover, the peaks in the range of 1700 to 1600 cm in the FTIR spectra of the esterified products indicated that the esterification of RE-SCFA was successful. The TGA results revealed that the RE-SCFA esters decomposed at lower temperatures than RE. The peaks in the LC-MS profiles of the esterified products indicated the formation of mono- and diesters, and the calculated monoester synthesis rates ranged between 45.81 and 49.64%. The RE esters inhibited the Cu-induced low-density lipoprotein oxidation reaction, exhibited antioxidant activity in bulk oil, and effectively inhibited the hydroxyl radical-induced DNA scission. Moreover, the RE-SCFA esters had better hydrogen peroxide scavenging activity than RE. Our results are the first in the literature to successfully including short chain fatty acids in the esters of resveratrol, and the products could be used as a functional food ingredient in processed foods or can be used as dietary supplements to promote health.
为了拓展白藜芦醇(RE)的应用范围,增强其稳定性和生物活性,并同时纳入短链脂肪酸(SCFA)的潜在健康益处,分别通过与乙酸、丙酸和丁酸的施陶丁格反应制备了RE的SCFA酯。使用核磁共振(NMR)、傅里叶变换红外(FTIR)光谱、热重分析(TGA)、差示热分析(DTA)和液相色谱 - 质谱联用(LC - MS)对RE及酯化后的RE - SCFA产物(包括RAE、RPE和RBE)进行了分析。酯化产物的FTIR光谱和碳核磁共振谱分别在1751 cm和171 ppm处出现了酯特征峰。此外,酯化产物FTIR光谱中1700至1600 cm范围内的峰表明RE - SCFA的酯化反应成功。TGA结果显示,RE - SCFA酯比RE在更低温度下分解。酯化产物的LC - MS图谱中的峰表明形成了单酯和二酯,计算得到的单酯合成率在45.81%至49.64%之间。RE酯抑制了铜诱导的低密度脂蛋白氧化反应,在散装油中表现出抗氧化活性,并有效抑制了羟基自由基诱导的DNA断裂。此外,RE - SCFA酯比RE具有更好的过氧化氢清除活性。我们的研究结果是文献中首次成功将短链脂肪酸纳入白藜芦醇酯中,这些产物可作为加工食品中的功能性食品成分,或用作促进健康的膳食补充剂。